HQP1351

· Ascentage Pharma Group Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for HQP1351, covering 2022-12-08 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HQP1351 in Patients With GIST or Other Solid Tumors [Phase 1]